Waters Corporation has reported its financial results for the third quarter of 2026, showcasing a robust performance that exceeded revenue expectations. The company announced total revenue of $1.767 billion, surpassing the guidance midpoint by $14 million, largely driven by organic growth in its Analytical Sciences and Biosciences divisions.
This update is significant as it highlights Waters Corporation's ability to capitalize on increasing demand for laboratory analytical instruments. The company’s strong performance may influence its competitors in the industry, pushing them to enhance their product offerings and services.
Background
Waters Corporation, incorporated in Delaware, operates in the laboratory analytical instruments sector (SIC: 3826). The company is publicly traded on the New York Stock Exchange under the ticker symbol WAT. Its recent filings include an 8-K on November 3, 2026, detailing its operational results and financial condition.
What the Filing Says
According to the filing, “Total reported revenue of $1.767 billion exceeded guidance midpoint by $14 million, led by organic revenue growth of 9% as reported and 10% in constant currency.” The company also reported a GAAP earnings per share (EPS) of $0.82, while the adjusted EPS grew 21% to $4.10, exceeding expectations.
Impact
The strong financial results are likely to impact various stakeholders, including investors, employees, and competitors in the laboratory analytical instruments industry. Investors may view this performance favorably, potentially increasing confidence in the company's future prospects. Employees may benefit from the company’s growth, which could lead to job security and potential bonuses. Competitors may need to reassess their strategies to keep pace with Waters Corporation's advancements.
What's Next
The company is set to provide a starting growth framework for 2027 during its earnings conference call scheduled for today at 8:00 a.m. ET. This will outline how various factors, including reshoring and AI-related demand drivers, are expected to shape the company's future growth.
Overall, Waters Corporation's latest financial results reflect a strong position in the laboratory analytical instruments market, with promising growth prospects ahead.
Read Next
DigitalOcean Reports Strong Q3 Results, Continues Growth
Amalgamated Financial Corp. files quarterly results, plans debt redemption
AEON Biopharma amends milestone warrants, lowers exercise prices
Chegg, Inc. Releases Third-Quarter Results for 2026
Aptiv PLC reports Q3 2026 financial results and updates
Giftify, Inc. Reports Strong Q3 Results and Growth Outlook









